Global Testosterone Replacement Therapy

Testosterone Replacement Therapy Comprehensive Study by Type (Creams or Gels, Patches, Injections, Buccal Adhesives, Implants, Oral), Application (Hospitals, Clinics) Players and Region - Global Market Outlook to 2026

Testosterone Replacement Therapy Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Testosterone is responsible for the development of male sexual characteristics and this hormone formed by the testicles. Insufficient production of testosterone causes erectile dysfunction. Testosterone Replacement Therapy (TRT) is generally termed as hormone therapy for men, designed to counteract the effects of reduced activity in the gonads or hypogonadism. Hypogonadism in men is clinical syndrome, which results in the failure of the testes to produce physiological levels of testosterone. Erectile dysfunction arises due to reduce testosterone production to overcome this testosterone replacement therapy is used to improve the problem.This growth is primarily driven by Increasing prevalence of hypogonadism in adult men and The need for having an offspring amongst men.

Globally, a noticeable market trend is evident Increasing awareness about testosterone substitute therapy. Major Players, such as AbbVie Inc. (United States), Endo International (Ireland), Eli Lilly and Company (United States), Pfizer (United States), Bayer (Germany), Actavis (Allergan) (United States), Novartis (Switzerland), Teva (Israel), Ferring Pharmaceuticals (Switzerland), Kyowa Kirin (Japan) and Mylan (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
Ferring Pharmaceuticals and Merck, known as MSD outside the United States and Canada, through its Merck for Mothers initiative, today announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), the world’s largest clinical trial in postpartum hemorrhage, is being undertaken to compare the effectiveness and safety of heat-stable carbetocin to oxytocin in the prevention of postpartum hemorrhage after vaginal births.

Market Drivers
  • Increasing prevalence of hypogonadism in adult men
  • The need for having an offspring amongst men

Market Trend
  • Increasing awareness about testosterone substitute therapy

Restraints
  • High possibility of side effects related to testosterone replacement therapy

Opportunities
Increasing investment on infrastructure in developing countries
Challenges
Risk of developing cardiovascular diseases and Risk of prostate cancer

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Testosterone Replacement Therapy Study Sheds Light on
— The Testosterone Replacement Therapy Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Testosterone Replacement Therapy industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Testosterone Replacement Therapy industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Creams or Gels
  • Patches
  • Injections
  • Buccal Adhesives
  • Implants
  • Oral
By Application
  • Hospitals
  • Clinics
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of hypogonadism in adult men
      • 3.2.2. The need for having an offspring amongst men
    • 3.3. Market Challenges
      • 3.3.1. Risk of developing cardiovascular diseases
      • 3.3.2. Risk of prostate cancer
    • 3.4. Market Trends
      • 3.4.1. Increasing awareness about testosterone substitute therapy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Testosterone Replacement Therapy, by Type, Application and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Testosterone Replacement Therapy (Value)
      • 5.2.1. Global Testosterone Replacement Therapy by: Type (Value)
        • 5.2.1.1. Creams or Gels
        • 5.2.1.2. Patches
        • 5.2.1.3. Injections
        • 5.2.1.4. Buccal Adhesives
        • 5.2.1.5. Implants
        • 5.2.1.6. Oral
      • 5.2.2. Global Testosterone Replacement Therapy by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
      • 5.2.3. Global Testosterone Replacement Therapy Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Testosterone Replacement Therapy (Volume)
      • 5.3.1. Global Testosterone Replacement Therapy by: Type (Volume)
        • 5.3.1.1. Creams or Gels
        • 5.3.1.2. Patches
        • 5.3.1.3. Injections
        • 5.3.1.4. Buccal Adhesives
        • 5.3.1.5. Implants
        • 5.3.1.6. Oral
      • 5.3.2. Global Testosterone Replacement Therapy by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
      • 5.3.3. Global Testosterone Replacement Therapy Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Testosterone Replacement Therapy (Price)
      • 5.4.1. Global Testosterone Replacement Therapy by: Type (Price)
  • 6. Testosterone Replacement Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AbbVie Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Endo International (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Eli Lilly and Company (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Actavis (Allergan) (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novartis (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Teva (Israel)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Ferring Pharmaceuticals (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kyowa Kirin (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Mylan (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Testosterone Replacement Therapy Sale, by Type, Application and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Testosterone Replacement Therapy (Value)
      • 7.2.1. Global Testosterone Replacement Therapy by: Type (Value)
        • 7.2.1.1. Creams or Gels
        • 7.2.1.2. Patches
        • 7.2.1.3. Injections
        • 7.2.1.4. Buccal Adhesives
        • 7.2.1.5. Implants
        • 7.2.1.6. Oral
      • 7.2.2. Global Testosterone Replacement Therapy by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
      • 7.2.3. Global Testosterone Replacement Therapy Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Testosterone Replacement Therapy (Volume)
      • 7.3.1. Global Testosterone Replacement Therapy by: Type (Volume)
        • 7.3.1.1. Creams or Gels
        • 7.3.1.2. Patches
        • 7.3.1.3. Injections
        • 7.3.1.4. Buccal Adhesives
        • 7.3.1.5. Implants
        • 7.3.1.6. Oral
      • 7.3.2. Global Testosterone Replacement Therapy by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
      • 7.3.3. Global Testosterone Replacement Therapy Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Testosterone Replacement Therapy (Price)
      • 7.4.1. Global Testosterone Replacement Therapy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Testosterone Replacement Therapy: by Type(USD Million)
  • Table 2. Testosterone Replacement Therapy Creams or Gels , by Region USD Million (2015-2020)
  • Table 3. Testosterone Replacement Therapy Patches , by Region USD Million (2015-2020)
  • Table 4. Testosterone Replacement Therapy Injections , by Region USD Million (2015-2020)
  • Table 5. Testosterone Replacement Therapy Buccal Adhesives , by Region USD Million (2015-2020)
  • Table 6. Testosterone Replacement Therapy Implants , by Region USD Million (2015-2020)
  • Table 7. Testosterone Replacement Therapy Oral , by Region USD Million (2015-2020)
  • Table 8. Testosterone Replacement Therapy: by Application(USD Million)
  • Table 9. Testosterone Replacement Therapy Hospitals , by Region USD Million (2015-2020)
  • Table 10. Testosterone Replacement Therapy Clinics , by Region USD Million (2015-2020)
  • Table 11. South America Testosterone Replacement Therapy, by Country USD Million (2015-2020)
  • Table 12. South America Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 13. South America Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 14. Brazil Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 15. Brazil Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 16. Argentina Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 17. Argentina Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 18. Rest of South America Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 19. Rest of South America Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 20. Asia Pacific Testosterone Replacement Therapy, by Country USD Million (2015-2020)
  • Table 21. Asia Pacific Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 22. Asia Pacific Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 23. China Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 24. China Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 25. Japan Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 26. Japan Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 27. India Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 28. India Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 29. South Korea Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 30. South Korea Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 31. Taiwan Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 32. Taiwan Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 33. Australia Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 34. Australia Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 36. Rest of Asia-Pacific Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 37. Europe Testosterone Replacement Therapy, by Country USD Million (2015-2020)
  • Table 38. Europe Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 39. Europe Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 40. Germany Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 41. Germany Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 42. France Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 43. France Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 44. Italy Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 45. Italy Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 46. United Kingdom Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 47. United Kingdom Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 48. Netherlands Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 49. Netherlands Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 50. Rest of Europe Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 51. Rest of Europe Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 52. MEA Testosterone Replacement Therapy, by Country USD Million (2015-2020)
  • Table 53. MEA Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 54. MEA Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 55. Middle East Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 56. Middle East Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 57. Africa Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 58. Africa Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 59. North America Testosterone Replacement Therapy, by Country USD Million (2015-2020)
  • Table 60. North America Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 61. North America Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 62. United States Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 63. United States Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 64. Canada Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 65. Canada Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 66. Mexico Testosterone Replacement Therapy, by Type USD Million (2015-2020)
  • Table 67. Mexico Testosterone Replacement Therapy, by Application USD Million (2015-2020)
  • Table 68. Testosterone Replacement Therapy Sales: by Type(ml)
  • Table 69. Testosterone Replacement Therapy Sales Creams or Gels , by Region ml (2015-2020)
  • Table 70. Testosterone Replacement Therapy Sales Patches , by Region ml (2015-2020)
  • Table 71. Testosterone Replacement Therapy Sales Injections , by Region ml (2015-2020)
  • Table 72. Testosterone Replacement Therapy Sales Buccal Adhesives , by Region ml (2015-2020)
  • Table 73. Testosterone Replacement Therapy Sales Implants , by Region ml (2015-2020)
  • Table 74. Testosterone Replacement Therapy Sales Oral , by Region ml (2015-2020)
  • Table 75. Testosterone Replacement Therapy Sales: by Application(ml)
  • Table 76. Testosterone Replacement Therapy Sales Hospitals , by Region ml (2015-2020)
  • Table 77. Testosterone Replacement Therapy Sales Clinics , by Region ml (2015-2020)
  • Table 78. South America Testosterone Replacement Therapy Sales, by Country ml (2015-2020)
  • Table 79. South America Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 80. South America Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 81. Brazil Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 82. Brazil Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 83. Argentina Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 84. Argentina Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 85. Rest of South America Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 86. Rest of South America Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 87. Asia Pacific Testosterone Replacement Therapy Sales, by Country ml (2015-2020)
  • Table 88. Asia Pacific Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 89. Asia Pacific Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 90. China Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 91. China Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 92. Japan Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 93. Japan Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 94. India Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 95. India Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 96. South Korea Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 97. South Korea Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 98. Taiwan Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 99. Taiwan Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 100. Australia Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 101. Australia Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 102. Rest of Asia-Pacific Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 103. Rest of Asia-Pacific Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 104. Europe Testosterone Replacement Therapy Sales, by Country ml (2015-2020)
  • Table 105. Europe Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 106. Europe Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 107. Germany Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 108. Germany Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 109. France Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 110. France Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 111. Italy Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 112. Italy Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 113. United Kingdom Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 114. United Kingdom Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 115. Netherlands Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 116. Netherlands Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 117. Rest of Europe Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 118. Rest of Europe Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 119. MEA Testosterone Replacement Therapy Sales, by Country ml (2015-2020)
  • Table 120. MEA Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 121. MEA Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 122. Middle East Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 123. Middle East Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 124. Africa Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 125. Africa Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 126. North America Testosterone Replacement Therapy Sales, by Country ml (2015-2020)
  • Table 127. North America Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 128. North America Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 129. United States Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 130. United States Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 131. Canada Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 132. Canada Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 133. Mexico Testosterone Replacement Therapy Sales, by Type ml (2015-2020)
  • Table 134. Mexico Testosterone Replacement Therapy Sales, by Application ml (2015-2020)
  • Table 135. Testosterone Replacement Therapy: by Type(USD/Units)
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Testosterone Replacement Therapy: by Type(USD Million)
  • Table 148. Testosterone Replacement Therapy Creams or Gels , by Region USD Million (2021-2026)
  • Table 149. Testosterone Replacement Therapy Patches , by Region USD Million (2021-2026)
  • Table 150. Testosterone Replacement Therapy Injections , by Region USD Million (2021-2026)
  • Table 151. Testosterone Replacement Therapy Buccal Adhesives , by Region USD Million (2021-2026)
  • Table 152. Testosterone Replacement Therapy Implants , by Region USD Million (2021-2026)
  • Table 153. Testosterone Replacement Therapy Oral , by Region USD Million (2021-2026)
  • Table 154. Testosterone Replacement Therapy: by Application(USD Million)
  • Table 155. Testosterone Replacement Therapy Hospitals , by Region USD Million (2021-2026)
  • Table 156. Testosterone Replacement Therapy Clinics , by Region USD Million (2021-2026)
  • Table 157. South America Testosterone Replacement Therapy, by Country USD Million (2021-2026)
  • Table 158. South America Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 159. South America Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 160. Brazil Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 161. Brazil Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 162. Argentina Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 163. Argentina Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 164. Rest of South America Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 165. Rest of South America Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 166. Asia Pacific Testosterone Replacement Therapy, by Country USD Million (2021-2026)
  • Table 167. Asia Pacific Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 168. Asia Pacific Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 169. China Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 170. China Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 171. Japan Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 172. Japan Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 173. India Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 174. India Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 175. South Korea Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 176. South Korea Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 177. Taiwan Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 178. Taiwan Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 179. Australia Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 180. Australia Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 181. Rest of Asia-Pacific Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 182. Rest of Asia-Pacific Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 183. Europe Testosterone Replacement Therapy, by Country USD Million (2021-2026)
  • Table 184. Europe Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 185. Europe Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 186. Germany Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 187. Germany Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 188. France Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 189. France Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 190. Italy Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 191. Italy Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 192. United Kingdom Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 193. United Kingdom Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 194. Netherlands Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 195. Netherlands Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 196. Rest of Europe Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 197. Rest of Europe Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 198. MEA Testosterone Replacement Therapy, by Country USD Million (2021-2026)
  • Table 199. MEA Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 200. MEA Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 201. Middle East Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 202. Middle East Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 203. Africa Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 204. Africa Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 205. North America Testosterone Replacement Therapy, by Country USD Million (2021-2026)
  • Table 206. North America Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 207. North America Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 208. United States Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 209. United States Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 210. Canada Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 211. Canada Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 212. Mexico Testosterone Replacement Therapy, by Type USD Million (2021-2026)
  • Table 213. Mexico Testosterone Replacement Therapy, by Application USD Million (2021-2026)
  • Table 214. Testosterone Replacement Therapy Sales: by Type(ml)
  • Table 215. Testosterone Replacement Therapy Sales Creams or Gels , by Region ml (2021-2026)
  • Table 216. Testosterone Replacement Therapy Sales Patches , by Region ml (2021-2026)
  • Table 217. Testosterone Replacement Therapy Sales Injections , by Region ml (2021-2026)
  • Table 218. Testosterone Replacement Therapy Sales Buccal Adhesives , by Region ml (2021-2026)
  • Table 219. Testosterone Replacement Therapy Sales Implants , by Region ml (2021-2026)
  • Table 220. Testosterone Replacement Therapy Sales Oral , by Region ml (2021-2026)
  • Table 221. Testosterone Replacement Therapy Sales: by Application(ml)
  • Table 222. Testosterone Replacement Therapy Sales Hospitals , by Region ml (2021-2026)
  • Table 223. Testosterone Replacement Therapy Sales Clinics , by Region ml (2021-2026)
  • Table 224. South America Testosterone Replacement Therapy Sales, by Country ml (2021-2026)
  • Table 225. South America Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 226. South America Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 227. Brazil Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 228. Brazil Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 229. Argentina Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 230. Argentina Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 231. Rest of South America Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 232. Rest of South America Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 233. Asia Pacific Testosterone Replacement Therapy Sales, by Country ml (2021-2026)
  • Table 234. Asia Pacific Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 235. Asia Pacific Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 236. China Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 237. China Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 238. Japan Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 239. Japan Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 240. India Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 241. India Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 242. South Korea Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 243. South Korea Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 244. Taiwan Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 245. Taiwan Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 246. Australia Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 247. Australia Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 248. Rest of Asia-Pacific Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 249. Rest of Asia-Pacific Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 250. Europe Testosterone Replacement Therapy Sales, by Country ml (2021-2026)
  • Table 251. Europe Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 252. Europe Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 253. Germany Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 254. Germany Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 255. France Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 256. France Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 257. Italy Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 258. Italy Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 259. United Kingdom Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 260. United Kingdom Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 261. Netherlands Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 262. Netherlands Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 263. Rest of Europe Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 264. Rest of Europe Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 265. MEA Testosterone Replacement Therapy Sales, by Country ml (2021-2026)
  • Table 266. MEA Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 267. MEA Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 268. Middle East Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 269. Middle East Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 270. Africa Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 271. Africa Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 272. North America Testosterone Replacement Therapy Sales, by Country ml (2021-2026)
  • Table 273. North America Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 274. North America Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 275. United States Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 276. United States Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 277. Canada Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 278. Canada Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 279. Mexico Testosterone Replacement Therapy Sales, by Type ml (2021-2026)
  • Table 280. Mexico Testosterone Replacement Therapy Sales, by Application ml (2021-2026)
  • Table 281. Testosterone Replacement Therapy: by Type(USD/Units)
  • Table 282. Research Programs/Design for This Report
  • Table 283. Key Data Information from Secondary Sources
  • Table 284. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Testosterone Replacement Therapy: by Type USD Million (2015-2020)
  • Figure 5. Global Testosterone Replacement Therapy: by Application USD Million (2015-2020)
  • Figure 6. South America Testosterone Replacement Therapy Share (%), by Country
  • Figure 7. Asia Pacific Testosterone Replacement Therapy Share (%), by Country
  • Figure 8. Europe Testosterone Replacement Therapy Share (%), by Country
  • Figure 9. MEA Testosterone Replacement Therapy Share (%), by Country
  • Figure 10. North America Testosterone Replacement Therapy Share (%), by Country
  • Figure 11. Global Testosterone Replacement Therapy: by Type ml (2015-2020)
  • Figure 12. Global Testosterone Replacement Therapy: by Application ml (2015-2020)
  • Figure 13. South America Testosterone Replacement Therapy Share (%), by Country
  • Figure 14. Asia Pacific Testosterone Replacement Therapy Share (%), by Country
  • Figure 15. Europe Testosterone Replacement Therapy Share (%), by Country
  • Figure 16. MEA Testosterone Replacement Therapy Share (%), by Country
  • Figure 17. North America Testosterone Replacement Therapy Share (%), by Country
  • Figure 18. Global Testosterone Replacement Therapy: by Type USD/Units (2015-2020)
  • Figure 19. Global Testosterone Replacement Therapy share by Players 2020 (%)
  • Figure 20. Global Testosterone Replacement Therapy share by Players (Top 3) 2020(%)
  • Figure 21. Global Testosterone Replacement Therapy share by Players (Top 5) 2020(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. AbbVie Inc. (United States) Revenue: by Geography 2020
  • Figure 25. Endo International (Ireland) Revenue, Net Income and Gross profit
  • Figure 26. Endo International (Ireland) Revenue: by Geography 2020
  • Figure 27. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 28. Eli Lilly and Company (United States) Revenue: by Geography 2020
  • Figure 29. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfizer (United States) Revenue: by Geography 2020
  • Figure 31. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Bayer (Germany) Revenue: by Geography 2020
  • Figure 33. Actavis (Allergan) (United States) Revenue, Net Income and Gross profit
  • Figure 34. Actavis (Allergan) (United States) Revenue: by Geography 2020
  • Figure 35. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Novartis (Switzerland) Revenue: by Geography 2020
  • Figure 37. Teva (Israel) Revenue, Net Income and Gross profit
  • Figure 38. Teva (Israel) Revenue: by Geography 2020
  • Figure 39. Ferring Pharmaceuticals (Switzerland) Revenue, Net Income and Gross profit
  • Figure 40. Ferring Pharmaceuticals (Switzerland) Revenue: by Geography 2020
  • Figure 41. Kyowa Kirin (Japan) Revenue, Net Income and Gross profit
  • Figure 42. Kyowa Kirin (Japan) Revenue: by Geography 2020
  • Figure 43. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 44. Mylan (United States) Revenue: by Geography 2020
  • Figure 45. Global Testosterone Replacement Therapy: by Type USD Million (2021-2026)
  • Figure 46. Global Testosterone Replacement Therapy: by Application USD Million (2021-2026)
  • Figure 47. South America Testosterone Replacement Therapy Share (%), by Country
  • Figure 48. Asia Pacific Testosterone Replacement Therapy Share (%), by Country
  • Figure 49. Europe Testosterone Replacement Therapy Share (%), by Country
  • Figure 50. MEA Testosterone Replacement Therapy Share (%), by Country
  • Figure 51. North America Testosterone Replacement Therapy Share (%), by Country
  • Figure 52. Global Testosterone Replacement Therapy: by Type ml (2021-2026)
  • Figure 53. Global Testosterone Replacement Therapy: by Application ml (2021-2026)
  • Figure 54. South America Testosterone Replacement Therapy Share (%), by Country
  • Figure 55. Asia Pacific Testosterone Replacement Therapy Share (%), by Country
  • Figure 56. Europe Testosterone Replacement Therapy Share (%), by Country
  • Figure 57. MEA Testosterone Replacement Therapy Share (%), by Country
  • Figure 58. North America Testosterone Replacement Therapy Share (%), by Country
  • Figure 59. Global Testosterone Replacement Therapy: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • AbbVie Inc. (United States)
  • Endo International (Ireland)
  • Eli Lilly and Company (United States)
  • Pfizer (United States)
  • Bayer (Germany)
  • Actavis (Allergan) (United States)
  • Novartis (Switzerland)
  • Teva (Israel)
  • Ferring Pharmaceuticals (Switzerland)
  • Kyowa Kirin (Japan)
  • Mylan (United States)
Additional players considered in the study are as follows:
Acerus Pharmaceuticals (Canada) , Perrigo Company plc (Ireland) , Upsher-Smith (United States)
Select User Access Type

Key Highlights of Report


Oct 2021 219 Pages 76 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Testosterone Replacement Therapy Quantitative research analysis
Global Testosterone Replacement Therapy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Testosterone Replacement Therapy Market are AbbVie Inc. (United States), Endo International (Ireland), Eli Lilly and Company (United States), Pfizer (United States), Bayer (Germany), Actavis (Allergan) (United States), Novartis (Switzerland), Teva (Israel), Ferring Pharmaceuticals (Switzerland), Kyowa Kirin (Japan) and Mylan (United States) etc.
Testosterone is responsible for the development of male sexual characteristics and this hormone formed by the testicles. Insufficient production of testosterone causes erectile dysfunction. Testosterone Replacement Therapy (TRT) is generally termed as hormone therapy for men, designed to counteract the effects of reduced activity in the gonads or hypogonadism. Hypogonadism in men is clinical syndrome, which results in the failure of the testes to produce physiological levels of testosterone. Erectile dysfunction arises due to reduce testosterone production to overcome this testosterone replacement therapy is used to improve the problem.

Know More About Global Testosterone Replacement Therapy Report?

Have a Query? Click Here

Other Related Reports

Loratadine Syrup Comprehensive Study by Application (Runny nose & Sneezing, Itchy, watery eyes, Itching of the nose or throat), End User (Adults and Children 6 years of age and above, Children 2 to u...
$ 3350
Calcium Supplement Comprehensive Study by Type (Children, Adult, The Aged), Application (Nutraceutical and supplements, Calcium Deficiency, Fitness purpose), End Users (Pharmacy, Hospital, Online, Ot...
$ 3450
Autoimmune Drugs Comprehensive Study by Type (B cell inhibitors, T cell inhibitors, Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Immunosuppressants, Beta Interferons, Insulin, Others), A...
$ 3750
Video Cystoscopes Comprehensive Study by Type (Flexible Cystoscopy, Rigid Cystoscopy), Application (Hospitals, Ambulatory Surgical Centers, Others), Length (37 cm, 40 cm), Cystoscopes Ranges (14 F, 1...
$ 3800
Oral Antiplatelets Comprehensive Study by Type (Irreversible Cyclooxygenase Inhibitors , ADP Receptor Inhibitors , Phosphodiesterase Inhibitors), Application (Acute Coronary Syndrome, Post Percutaneo...
$ 3750
Genitourinary Drugs Comprehensive Study by Type (Urologicals, Hormonal Therapy, Gynecological, Anti-infectives), Drug Type (Hormonal Therapy, Targeted Drugs, Urinary Antispasmodics, Uterine relaxants...
$ 3750